Document is current
Any future updates will be listed below
-
Authors
Tabata, Junya https://orcid.org/0000-0001-8442-8546
Huang, Tzu-Ting https://orcid.org/0000-0002-3675-2760
Giudice, Elena https://orcid.org/0000-0002-8763-6815
Ibanez, Kristen R.
Nair, Jayakumar R.
Warner, Aanika Balaji https://orcid.org/0000-0001-6697-3364
Solarz, Britanny B.
Bolanos, Valentina
Redd, Bernadette https://orcid.org/0000-0001-9058-9485
Sato, Nahoko https://orcid.org/0009-0007-1772-3183
Rastogi, Shraddha https://orcid.org/0000-0003-0680-0407
Lee, Sunmin https://orcid.org/0000-0001-6011-151X
Shrestha, Roshan L.
Mitrophanov, Alexander Y. https://orcid.org/0000-0002-9019-4034
Lipkowitz, Stanley https://orcid.org/0000-0002-6103-2255
Conlon, Kevin
Huang, Chien Chu
Lee, Jung-Min
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (ZIA BC011525)
- License Information
-
More Information
Article History
Received: 26 September 2025
Accepted: 5 March 2026
First Online: 16 March 2026
Competing interests
: J.-M.L. had research grant funding from AstraZeneca and Acrivon Therapeutics (paid to institution) and was on the Scientific Advisory Board of Acrivon Therapeutics (unpaid). Dr. Lee is currently an employee of GSK. This research work was completed prior to joining GSK and has no competing interests with GSK. The remaining authors declare no competing interests.
